Syndax Pharmaceuticals (SNDX) Earnings
|
Expand Research on SNDX
| Next EPS Date | 8/10/26 | EPS Growth Rate | +42.2% |
|---|---|---|---|
| Average EPS % Beat Rate | +3.1% | Revenue Growth Rate | +110.6% |
| Average % Move 1-Wk after EPS | +8.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/26  |
Q226 | N/A | -$0.48 | N/A | N/A | $79.96M | N/A | N/A | N/A | ||
| 4/30/26 | Q126 | -$0.48 | -$0.62 | +$0.14 | $64.9M | $71.84M | N/A |  | | Details | |
| 2/26/26 | Q425 | -$0.78 | -$0.59 | -$0.19 | $68.7M | $63.13M | N/A | | | Details | |
| 11/3/25 | Q325 | -$0.70 | -$0.73 | +$0.03 | $45.9M | $47.75M | N/A | | | Details | |
| 8/4/25 | Q225 | -$0.83 | -$1.01 | +$0.18 | $37.96M | $27.13M | N/A | | | Details | |
| 5/5/25 | Q125 | -$0.98 | -$1.24 | +$0.26 | $20.04M | $14.84M | N/A | | | Details | |
| 3/3/25 |
Q424 | N/A | -$0.99 | N/A | N/A | $25.2M | N/A | N/A | N/A | ||
| 11/5/24 | Q324 | -$0.98 | -$1.07 | +$0.09 | $12.5M | $9.16M | N/A | | | Details |
